BioImagene teams with Rutgers, UPenn for digital pathology

Digital pathology solutions provider BioImagene has collaborated with the University of Pennsylvania School of Medicine in Philadelphia and Rutgers University in New Brunswick, N.J., in the development of diagnostic tool, Companion Algorithms.

The digital pathology tool is intended to diagnose and evaluate prostate cancer through the utilization of BioImagene’s iAnalytics framework and telepathology capabilities in the collaboration on the development and validation of algorithms for diagnostic use, according to the Sunnyvale, Calif.-based company.

Researchers and clinicians from both respective universities will digitize standard prostate biopsy samples by way of BioImagene’s Virtuoso framework, said BioImagene.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.